PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial. Issue 200 (April 2021)

Record Type:: Journal Article
Title:: PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial. Issue 200 (April 2021)
Main Title:: PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial
Authors:: Marshall, A.
Young, A.M.
Levine, M.
Hill, C.
Hale, D.
Thirlwall, J.
Wilkie, V.
French, K.
Kakkar, A.K.
Lokare, A.
Maraveyas, A.
Chapman, O.
Arif, A.
Petrou, S.
Maredza, M.
Hobbs, F.D.R.
Dunn, J.A.
Abstract:
Is Part Of:: Thrombosis research. Issue 200(2021)Supplement 1
Journal:: Thrombosis research
Issue:: Issue 200(2021)Supplement 1
Issue Display:: Volume 200, Issue 1 (2021)
Year:: 2021
Volume:: 200
Issue:: 1
Issue Sort Value:: 2021-0200-0001-0000
Page Start:: S36
Page End:
Publication Date:: 2021-04
Subjects:: Thrombosis -- Periodicals
616.135
Journal URLs:: http://www.sciencedirect.com/science/journal/00493848 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0049-3848(21)00209-7 ↗
Languages:: English
ISSNs:: 0049-3848
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8820.365000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16895.xml